Systems and methods for dispensing a statin medication over the counter

A method for qualifying a human subject for delivery of a statin pharmaceutical composition over the counter to lower cholesterol, the method comprising:

• a) conducting a first survey of the subject thereby obtaining a first plurality of survey results, wherein the first plurality of survey results comprises:
• a sex of the subject,
• whether the subject is female and one of (i) pregnant, (ii) breastfeeding, or (iii) planning to become pregnant,
• whether the subject has or has ever had a liver disease,
• an age of the subject,
• a total cholesterol level of the subject,
• a HDL cholesterol count of the subject,
• a systolic blood pressure of the subject,
• a race of the subject,
• whether the subject is taking a high blood pressure medication,
• whether the subject is taking one or more medications that interact with the statin pharmaceutical composition, wherein the one or more medications include cyclosporine,
• a smoking status of the subject,
• a diabetes status of the subject,
• an alcohol consumption status of the subject,
• whether the subject has had an adverse reaction to a cholesterol lowering medication, and
• whether the subject has ever had an atherosclerotic cardiovascular event or had a heart procedure;
• b) running all or a portion of the first plurality of survey results against a first plurality of filters of a first category class, wherein, when a respective filter in the first plurality of filters is fired, the subject is deemed not qualified for delivery of the statin pharmaceutical composition and the method is terminated without delivery of the statin pharmaceutical composition to the subject, wherein the first plurality of filters comprises:
• a pregnancy filter,
• a cyclosporine filter, and
• a liver disease filter,
• c) running all or a portion of the first plurality of survey results against a second plurality of filters of a second category class, wherein, when a respective filter in the second plurality of filters is fired, the subject is provided with a warning corresponding to the respective filter, and wherein the second plurality of filters comprises:
• a total cholesterol level filter,
• a pooled cohort equation filter that incorporates the sex of the subject, the race of the subject, the age of the subject, the total cholesterol level of the subject, the HDL cholesterol count of the subject, the systolic blood pressure of the subject, whether the subject is taking a medication that interacts with a statin, the smoking status of the subject, and the diabetes status of the subject to derive a risk for the atherosclerotic cardiovascular disease, wherein when the risk satisfies a first threshold range or a first threshold value the pooled cohort equation filter is deemed fired,
• an age filter,
• a drug interaction filter,
• an alcohol consumption filter,
• an adverse reaction filter, and
• an atherosclerotic cardiovascular event filter;
• d) obtaining acknowledgment from the subject for the warning issued to the subject by any filter in the second plurality of filters;
• and
• e) proceeding with a fulfillment process when (i) no filter in the first plurality of filters has been fired and (ii) the subject has acknowledged each warning associated with each filter in the second plurality of filters that was fired, wherein the fulfillment process comprises:
• storing an indication in a subject profile of an initial order for the statin pharmaceutical composition,
• communicating an over the counter drug facts label for the statin pharmaceutical composition to the subject, and
• authorizing, upon confirmation from the subject that the over the counter drug facts label has been received and read, provision of the statin pharmaceutical composition to the subject, wherein the authorization includes a destination associated with the subject.

A non-transitory computer readable storage medium, wherein the non-transitory computer readable storage medium stores instructions, which when executed by a computer system, cause a computer system to perform a method for qualifying a human subject for delivery of a statin pharmaceutical composition over the counter to lower cholesterol, the method comprising:

• a) conducting a first survey of the subject thereby obtaining a first plurality of survey results, wherein the first plurality of survey results comprises:
• a sex of the subject,
• whether the subject is female and one of (i) pregnant, (ii) breastfeeding, or (iii) planning to become pregnant,
• whether the subject has or has ever had a liver disease,
• an age of the subject,
• a total cholesterol level of the subject,
• a HDL cholesterol count of the subject,
• a systolic blood pressure of the subject,
• a race of the subject,
• whether the subject is taking a high blood pressure medication,
• whether the subject is taking one or more medications that interact with the statin pharmaceutical composition, wherein the one or more medications include cyclosporine,
• a smoking status of the subject,
• a diabetes status of the subject,
• an alcohol consumption status of the subject,
• whether the subject has had an adverse reaction to a cholesterol lowering medication, and
• whether the subject has ever had an atherosclerotic cardiovascular event or had a heart procedure;
• b) running all or a portion of the first plurality of survey results against a first plurality of filters of a first category class, wherein, when a respective filter in the first plurality of filters is fired, the subject is deemed not qualified for delivery of the statin pharmaceutical composition and the method is terminated without delivery of the statin pharmaceutical composition to the subject, wherein the first plurality of filters comprises:
• a pregnancy filter,
• a cyclosporine filter, and
• a liver disease filter,
• c) running all or a portion of the first plurality of survey results against a second plurality of filters of a second category class, wherein, when a respective filter in the second plurality of filters is fired, the subject is provided with a warning corresponding to the respective filter, and wherein the second plurality of filters comprises:
• a total cholesterol level filter,
• a pooled cohort equation filter that incorporates the sex of the subject, the race of the subject, the age of the subject, the total cholesterol level of the subject, the HDL cholesterol count of the subject, the systolic blood pressure of the subject, whether the subject is taking a medication that interacts with a statin, the smoking status of the subject, and the diabetes status of the subject to derive a risk for the atherosclerotic cardiovascular disease, wherein when the risk satisfies a first threshold range or a first threshold value the pooled cohort equation filter is deemed fired,
• an age filter,
• a drug interaction filter,
• an alcohol consumption filter,
• an adverse reaction filter, and
• an atherosclerotic cardiovascular event filter;
• d) obtaining acknowledgment from the subject for the warning issued to the subject by any filter in the second plurality of filters;
• and
• e) proceeding with a fulfillment process when (i) no filter in the first plurality of filters has been fired and (ii) the subject has acknowledged each warning associated with each filter in the second plurality of filters that was fired, wherein the fulfillment process comprises:
• storing an indication in a subject profile of an initial order for the statin pharmaceutical composition,
• communicating an over the counter drug facts label for the statin pharmaceutical composition to the subject, and
• authorizing, upon confirmation from the subject that the over the counter drug facts label has been received and read, provision of the statin pharmaceutical composition to the subject, wherein the authorization includes a destination associated with the subject.